Synthesis and evaluation of an F-18-labeled pyrimidine-pyridine amine for targeting CXCR4 receptors in gliomas

摘要

Introduction: Chemokine receptor-4 (CXCR4, fusin, CD184) is expressed on several tissues involved in immune regulation and is upregulated in many diseases including malignant gliomas. A radiolabeled small molecule that readily crosses the blood-brain barrier can aid in identifying CXCR4-expressing gliomas and monitoring CXCR4-targeted therapy. In the current work, we have synthesized and evaluated an [F-18]-labeled small molecule based on a pyrimidine-pyridine amine for its ability to target CXCR4.